Stage III Breast Cancer Linked to Paraneoplastic Neuromyelitis Optica
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage III
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- ER-positive, PR-positive, HER2-negative; tumor AQP4 expression
- Sex
- female
- Treatment
- surgery
Treatment course, step by step
- Underwent total left mastectomy with lymph-node dissection.
What happened, in summary
A 51-year-old woman was hospitalized with severe nausea, vomiting and fatigue. During the evaluation, CT unexpectedly found several nodules in her left breast. Her symptoms later progressed to leg weakness, numbness and difficulty urinating, and spinal imaging showed extensive transverse myelitis. Testing confirmed neuromyelitis optica spectrum disorder with AQP4 antibodies.
A biopsy of a left-breast tumor showed invasive ductal carcinoma that was estrogen-receptor positive, progesterone-receptor positive and HER2-negative. The tumor cells also expressed AQP4, supporting the conclusion that the neurologic illness was a rare paraneoplastic complication of her breast cancer.
She underwent total left mastectomy with lymph-node dissection. Surgical pathology confirmed poorly differentiated invasive ductal carcinoma, and the cancer was Stage III. Treatment for the neurologic disorder improved the severe nausea and vomiting and stopped further rapid neurologic decline. At discharge for rehabilitation, she remained wheelchair-dependent but no longer had the intractable gastrointestinal symptoms that had led to her hospitalization.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 3 Breast Cancer 131 stories
- ER Positive Breast Cancer 242 stories
- Mastectomy for ER Positive Breast Cancer 141 stories
- Mastectomy for Breast Cancer 624 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer